VENA, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 173
AS - Asia 103
EU - Europa 69
SA - Sud America 11
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 359
Nazione #
US - Stati Uniti d'America 170
SG - Singapore 30
CN - Cina 27
IT - Italia 18
HK - Hong Kong 17
RU - Federazione Russa 12
BR - Brasile 9
VN - Vietnam 8
FR - Francia 6
UA - Ucraina 6
DE - Germania 5
AT - Austria 4
FI - Finlandia 4
ID - Indonesia 4
IE - Irlanda 4
IN - India 4
RO - Romania 4
CA - Canada 3
JP - Giappone 3
BG - Bulgaria 2
ZA - Sudafrica 2
BD - Bangladesh 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EU - Europa 1
IL - Israele 1
IQ - Iraq 1
IR - Iran 1
KR - Corea 1
NL - Olanda 1
PK - Pakistan 1
PL - Polonia 1
SA - Arabia Saudita 1
SE - Svezia 1
TR - Turchia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 359
Città #
Singapore 29
Chandler 25
Beijing 22
Ashburn 19
Fairfield 18
Hong Kong 14
Wilmington 11
Houston 10
Woodbridge 9
Dong Ket 8
Boardman 6
Princeton 5
Seattle 5
Dublin 4
Canyon Country 3
Lappeenranta 3
Milan 3
Tokyo 3
Vienna 3
Bandung 2
Bologna 2
Cambridge 2
Durban 2
Düsseldorf 2
Grugliasco 2
Horia 2
Hyderabad 2
Salto 2
Santa Clara 2
Sofia 2
Ankara 1
Ann Arbor 1
Barquisimeto 1
Brooklyn 1
Calgary 1
Chicago 1
Des Moines 1
Dhaka 1
Erbil 1
Frankfurt am Main 1
Grafing 1
Guarapari 1
Haifa 1
Hefei 1
Helsinki 1
Itumbiara 1
Jakarta 1
Jeddah 1
Kish 1
Lahore 1
Lauterbourg 1
Leawood 1
Los Angeles 1
Maricá 1
Montreal 1
Norwalk 1
Ogden 1
Ottawa 1
Paris 1
Prague 1
Rio de Janeiro 1
Santa Marta 1
Seoul 1
Shenzhen 1
St Louis 1
São João da Boa Vista 1
São Paulo 1
Tashkent 1
Timisoara 1
Udine 1
Uruaçu 1
Warsaw 1
Totale 264
Nome #
Comparison of the Safety and Tolerance Profile of Micafungin with that of Other Echinocandins and Azoles in Patients with Pre-existing Child–Pugh B or C Liver Disease: A Case–Control Retrospective Study 84
Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome? 81
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians? 57
Factors associated with the development of septic shock in patients with candidemia: A post hoc analysis from two prospective cohorts 53
Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain 48
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 34
Omadacycline for the treatment of skin and soft tissue infections 16
Mortality of Pneumocystis jirovecii pneumonia in intensive care units: a post-hoc analysis of an international multicenter study by ESGCIP and EFISG 10
Totale 383
Categoria #
all - tutte 2.003
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.003


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202163 4 2 12 2 3 11 2 9 1 5 0 12
2021/202242 0 5 2 0 1 1 3 0 0 4 21 5
2022/202350 5 3 6 4 3 13 0 4 4 1 7 0
2023/202435 5 7 8 0 2 2 5 0 1 1 0 4
2024/2025121 4 8 8 3 6 9 9 6 20 13 14 21
2025/202621 21 0 0 0 0 0 0 0 0 0 0 0
Totale 383